Yanpeng Li | Pharmacology | Research Excellence Award

Published on by sciencefatherLeave a Comment on Yanpeng Li | Pharmacology | Research Excellence Award

Dr. Yanpeng Li | Pharmacology | Research Excellence Award

Shenzhen University | China

Dr. Yanpeng Li is a pharmacology researcher at Shenzhen University with interdisciplinary expertise spanning pharmaceutical chemistry, immunology, and targeted drug discovery. He earned his PhD in Pharmacology from Southern Medical University and completed joint doctoral training at the Karolinska Institutet under Nobel Committee member Prof. Rikard Holmdahl, where his research centered on natural medicinal flavonoids, particularly kaempferol, in autoimmune diseases and virus immunology. Dr. Li further strengthened his international research profile through postdoctoral training in viral immunology at the Karolinska Institutet and is currently pursuing postdoctoral research at Shenzhen University, focusing on targeted therapeutic strategies for acute myeloid leukemia. His academic and professional journey reflects a strong integration of basic pharmacological mechanisms with translational drug development. Dr. Li is an active member of several professional bodies, including the Editorial Board of the International Conference on Disease Genetics and Genomics, the Clinical Rational Drug Use Committee of the Shenzhen Medical Doctor Association, and the Swedish Pharmacists’ Association. His research interests encompass natural compounds, autoimmune disorders such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, viral immunology, acute myeloid leukemia, and precision-targeted therapies. In recognition of his academic excellence, he has received multiple scholarships and awards from institutions in China and Sweden. Overall, Dr. Li’s work contributes significantly to advancing targeted therapeutics and evidence-based pharmacological innovation.

View ORCID Profile

Featured Publications

Pengyuan Wang | Pancreatitis | Young Researcher Award

Published on by sciencefatherLeave a Comment on Pengyuan Wang | Pancreatitis | Young Researcher Award

Mr. Pengyuan Wang | Pancreatitis | Young Researcher Award

Department of Gastroenterology, Changhai Hospital, Naval Medical University | China

Mr. Pengyuan Wang is an accomplished biomedical researcher and clinician specializing in gastroenterology and translational pharmacology. He obtained a Bachelor’s degree in Clinical Medicine, followed by a Ph.D. in Pharmacology, and further strengthened his academic foundation through postdoctoral training in Gastroenterology. He is currently affiliated with leading clinical and research centers in China, where he integrates clinical insight with mechanistic research to address complex gastrointestinal diseases. His professional experience bridges patient-oriented practice and laboratory-based investigation, enabling a strong bench-to-bedside research approach. Mr. Wang’s primary research interest focuses on the metabolic mechanisms underlying pancreatitis, with particular emphasis on identifying key molecular pathways involved in disease initiation and progression. In parallel, he is actively engaged in drug screening and pharmacological evaluation, aiming to discover and optimize therapeutic candidates for pancreatitis and related metabolic disorders. His work contributes to improving diagnostic strategies and advancing targeted treatments in gastroenterology. Recognized for his rigorous scientific approach and interdisciplinary expertise, he has received academic acknowledgment through competitive research training and scholarly contributions. Overall, Mr. Wang’s research continues to enhance the understanding of pancreatitis pathophysiology and supports the development of innovative therapeutic interventions with significant clinical relevance.

View ORCID Profile

Featured Publications

Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Published on by sciencefather

Prof. Dr. Esmail El-Fakharany | Drug Delivery | Research Excellence Award

City of Scientific Research and Technological Applications | Egypt

Prof. Dr. Esmail El-Fakharany is a distinguished scientist affiliated with the Protein Research Department at the Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, where his work significantly advances biomedical and biotechnological research. He earned his Ph.D. in Microbiology with a minor specialization in biotechnology in 2012, following an M.Sc. in Microbiology with a focus on antiviral agents in 2009, both from the Faculty of Science, Al-Azhar University, Cairo. His academic foundation is further strengthened by a Diploma in Public Health Microbiology from the High Institute of Public Health, Alexandria University, and a B.Sc. in Microbiology with excellent distinction. Prof. Dr. El-Fakharany possesses extensive experience in immunology and immunoblotting, molecular biology, therapeutic protein and enzyme purification, antiviral and anticancer agent investigation, microbiological techniques, and tissue culture and cell line maintenance. His primary research interests center on antiviral proteins, recombinant and natural bioactive molecules, therapeutic protein engineering, immunological applications, and biotechnology-driven drug development. Through sustained scientific contributions, he has received professional recognition for excellence in microbiology and biotechnology research. Overall, his work continues to play a vital role in translating fundamental microbiological insights into innovative therapeutic strategies, contributing meaningfully to global health and applied life sciences.

View Google Scholar Profile

Featured Publications

Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study

Virology Journal, 2013, Vol. 10(1), Article 199

Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells

Protein & Peptide Letters, 2010, Vol. 17(8), pp. 1031–1039

Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and HeLa cell lines

Hepatitis Monthly, 2011, Vol. 11(9)

Potential lactoferrin activity against pathogenic viruses

Comptes Rendus Biologies, 2014, Vol. 337(10), pp. 581–595

Poly(vinyl alcohol)–hyaluronic acid membranes for wound dressing applications: synthesis and in vitro bio-evaluations

Journal of the Brazilian Chemical Society, 2015, Vol. 26(7), pp. 1466–1474

Sevgi Kolayli | Biochemistry | Research Excellence Award

Published on by sciencefather

Prof. Sevgi Kolayli | Biochemistry | Research Excellence Award

Karadeniz Technical university, Turkey

Prof. Dr. Sevgi Kolaylı is a distinguished biochemist at Karadeniz Technical University, serving in the Department of Biochemistry within the Chemistry Division, where she has built a notable academic and research career. She completed her higher education in chemistry and biochemistry, developing a strong foundation that shaped her specialization in natural product biochemistry. With extensive experience spanning more than a decade, she has authored around 150 peer-reviewed scientific publications that have collectively garnered approximately 7,500 citations, reflecting her influence and productivity in the global scientific community. Her primary research interests center on the biochemical properties, antioxidant potential, and therapeutic applications of bee products and other natural compounds, positioning her as a recognized expert in this niche field. She has supervised 15–20 master’s theses and 15 doctoral dissertations, contributing significantly to the academic development of young scientists. Prof. Kolaylı’s work has earned national and international appreciation, including recognition in high-impact journals and scientific platforms. Her continued dedication to advancing biochemistry through innovative research, academic mentorship, and contributions to natural product science underscores her commitment to enhancing scientific understanding and promoting beneficial applications of bioactive substances.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Cora, M., Esertas, U. Z. U., Kara, Y., & Kolayli, S. (2025). Antioxidant, antimicrobial, antiviral, and antiproliferative properties of Turkish propolis sample. European Food Research and Technology. https://doi.org/10.1007/S00217-024-04618-5

Bedjih, F., Ouchemoukh, S., Amessis-Ouchemoukh, N., Otmani, A., Zaidi, H., Kara, Y., Inan, C., Ozkan, I., & Kolayli, S. (2025). Biochemical properties of different Algerian bee pollen samples. Mediterranean Journal of Nutrition and Metabolism. https://doi.org/10.1177/1973798X251318583

Dursun, I., Kanbur, E. D., Kara, Y., & Kolayli, S. (2025). Determination of Grayanotoxin-III amount in the rhododendron honey and flowers samples using UHPLC-Orbitrap®-HRMS. Toxicon. https://doi.org/10.1016/J.TOXICON.2025.108294

Sahin, H., Kolayli, S., Kara, Y., Can, Z., Guler, H. I., Ozkok, A., & Serdar, U. (2024). A study on recognizing the value of chestnut (Castanea sativa) blossom waste. Tarim Bilimleri Dergisi. https://doi.org/10.15832/ANKUTBD.1172677

Can, Z., Kara, Y., Kolayli, S., & Cakmak, I. (2024). Antioxidant activity and phenolic composition of propolis from Marmara region, Turkey. Journal of Apicultural Research. https://doi.org/10.1080/00218839.2022.2157582

Can, Z., Gidik, B., Kara, Y., & Kolayli, S. (2024). Antioxidant activity and phenolic content of bee breads from different regions of Türkiye by chemometric analysis (PCA and HCA). European Food Research and Technology. https://doi.org/10.1007/S00217-024-04597-7

Gunes, M. E., Keskin, S., Alkan, P. E., Keskin, M., & Kolayli, S. (2024). Biochemical characterization and antimicrobial properties of ice cream enriched with antioxidant encapsulated propolis. Journal of Animal and Plant Sciences. https://doi.org/10.36899/JAPS.2024.1.0702

Yangyang Han | Nanomaterials | Research Excellence Award

Published on by sciencefather

Prof. Yangyang Han | Nanomaterials | Research Excellence Award

Shandong Second Medical University, China

Prof. Yangyang Han is a distinguished scholar and influential educator whose work spans biochemistry, molecular biology, and biomechanics. He holds a Ph.D. and has built a strong academic foundation that supports his role as a Professor and Master’s Supervisor. Over the years, he has served in several notable capacities, including Associate Professor, Lecturer, and Senior Visiting Scholar at the Institute of Mechanics, Chinese Academy of Sciences, where he deepened his expertise in molecular mechanisms and biomechanical processes. His professional journey includes leadership as Director of the Molecular Biology Teaching and Research Section and service as a Review Expert for the National Natural Science Foundation of China, reflecting his credibility in scientific evaluation and research guidance. As Leader of the Youth Innovation Team of Shandong Provincial Institutions of Higher Education and a Director within the Shandong Society of Biochemistry and Molecular Biology, he continues to foster scientific development and interdisciplinary collaboration. His research interests focus on molecular regulation, cellular biomechanics, and biomedical innovation, contributing to impactful advancements in the field. With recognition for his academic leadership and scientific service, Prof. Han remains committed to driving research excellence, nurturing emerging scholars, and advancing knowledge in life sciences.

Profiles: Scopus | Orcid

Featured Publications

Bai, L., Qian, X., Zhang, H., Yuan, Y., Cui, X., Cheng, M., & Han, Y. (2025). Plectin, a novel regulator in migration, invasion and adhesion of ovarian cancer. Cell & Bioscience. https://doi.org/10.1186/s13578-025-01349-2

Han, Y. (2020). RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells. Aging. https://doi.org/10.18632/aging.103906

Han, Y. (2020). Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discovery. https://doi.org/10.1038/s41420-020-0269-0

 

Weikai Zhang | Drug Discovery | Research Excellence Award

Published on by sciencefather

Dr. Weikai Zhang | Drug Discovery | Research Excellence Award

Luoyang Polytechnic, China

Dr. Weikai Zhang is a dedicated biomedical engineering researcher whose work centers on advancing single-cell technologies for improved antibody discovery and biomedical applications. He earned his PhD in Biomedical Engineering from the School of Life Science at the Beijing Institute of Technology, preceded by a Master’s degree from Henan University of Science and Technology and a Bachelor’s degree in Biotechnology from Xinyang Agricultural College. His academic journey included extensive joint master’s and doctoral research at the National Center for Nanoscience and Technology, where he investigated nanobiological effects and safety. Earlier in his career, he contributed as a technician in the Antibody Engineering Laboratory at the National Protein Science Center in Beijing, gaining foundational expertise in protein science and antibody development. Currently, he serves as a Lecturer and Deputy Director of the Key Engineering Technology Research Center for Immune Technology Biological Materials Preparation in Henan Province. His research focuses on designing and developing microfluidic chips for single-cell analysis, improving throughput and screening efficiency, and enhancing diagnostic and therapeutic antibody development. Recognized for his scientific contributions, he has received multiple honors, including youth talent awards and innovation recognitions. Dr. Zhang continues to advance impactful research in biomedical engineering and single-cell technology.

Profile: Orcid

Featured Publications

Zhang, W., Li, Q., Jia, F., Hu, Z., & Wei, Z. (2021). “A microfluidic chip for screening and sequencing of monoclonal antibody at a single-cell level.” Analytical Chemistry. https://doi.org/10.1021/acs.analchem.1c00918

 

Radwa Mahmoud | Biotechnology | Excellence in Research Award

Published on by sciencefather

Ms. Radwa Mahmoud | Biotechnology | Excellence in Research Award

Biotechnology Department, Faculty of Science, Cairo University, Egypt

Ms. Radwa Mahmoud is an emerging biotechnology researcher with strong expertise in cancer therapeutics, molecular diagnostics, and nanoparticle biosynthesis. She is currently pursuing a Master’s degree in Biotechnology at Cairo University, where she previously completed her Bachelor’s degree with distinction, ranking among the top students. Her research interests span breast cancer treatment using scorpion-venom-derived peptides, CRISPR-based microbiome engineering, antimicrobial peptides, and the biomedical applications of nanomaterials. Radwa has extensive hands-on experience in wet-lab experimentation, diagnostic assay design, cytotoxicity analysis, molecular cloning, protein purification, and computational modeling. She has led multidisciplinary research projects focused on early breast cancer detection and innovative therapeutic models, earning competitive funding support from the Science and Technology Development Fund (STDF) and winning awards such as Best Poster at SOLE and a Silver Medal at the international iGEM competition. Her professional experience includes roles in pharmaceutical research and development, molecular biology laboratories, and academic teaching support. Radwa’s growing publication record and contributions to translational research highlight her commitment to advancing oncology, biotechnology innovation, and therapeutic discovery. She aims to continue developing impactful scientific solutions addressing global health challenges.

Profiles: Scopus | Orcid

Featured Publications

Amen, R.A. (2024). “Harnessing plant extracts for skin health and dermatological care: herbal wonders green solutions” in Herbal Wonders Green Solutions.

Amen, R.A. (2024). “Therapeutic potential and characteristics of Smp43 peptide (scorpion venom) and its interaction with cellular signaling pathways: a review” in Review.

Amen, R.A. (2024). “Exploring the potential of natural compounds in cancer treatment: a review” in Review.

Amen, R.A. (2024). “Coinfection of schistosomiasis and hepatitis C in Egypt: challenges and possible management strategies” in Review.

Amen, R.A. (2024). “Biosynthesis of silver, copper, and their bi-metallic nanocomposites by Staphylococcus aureus: their antimicrobial, anticancer activity, and cytotoxicity effect” in Journal Article.

Amen, R.A. (2023). “COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic” in Review.

Amen, R.A. (2022). “Pharmacological properties of 4′, 5, 7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways” in Review.

Mawia Osman | Quantum Chemistry | Research Excellence Award

Published on by sciencefather

Dr. Mawia Osman | Quantum Chemistry | Research Excellence Award

China West Normal University, China

Dr. Mawia Osman is a dedicated researcher in advanced mathematical sciences, recognized for her work at the intersection of fuzzy systems, nonlinear dynamics, and computational analysis. She built a strong academic foundation through a BSc in Science and Technology, followed by qualifying studies in mathematical sciences, an MSc in pure and applied sciences, and a PhD in Mathematics and Statistics from Northwest Normal University, China. Her doctoral journey was supported by the prestigious Chinese Government Scholarship (CSC), awarded for excellence and potential in research. Throughout her academic progression, she has developed expertise in fuzzy analysis, fuzzy differential and fractional differential equations, nonlinear partial differential equations, fuzzy integral equations, and numerical analysis. Her broader research interests also extend to fuzzy mathematical modeling, quantum calculus, fractal calculus, nonlinear analysis, and biomedical research, reflecting a multidisciplinary vision. Dr. Osman’s scholarly work contributes to solving complex real-world problems using advanced mathematical frameworks, positioning her as a promising researcher in modern applied mathematics. Her commitment to research, continuous learning, and innovative thinking defines her professional identity, and she remains focused on expanding the theoretical and practical applications of fuzzy and nonlinear systems in scientific and technological advancements.

Profiles: Orcid | Google Scholar

Featured Publications

Shah, S.O., Tikare, S., & Osman, M. (2023). Ulam Type Stability Results of Nonlinear Impulsive Volterra–Fredholm Integro-Dynamic Adjoint Equations on Time Scale. Mathematics, 11(21).

Ali, U., & Osman, M. (2023). On Consequences of Carreau Nanofluid Model with Dufour–Soret Effects and Activation Energy Subject to New Mass Flux Condition: A Numerical Study. Mathematics, 11(11).

Osman, M., Xia, Y., Omer, O.A., & Hamoud, A. (2022). On the Fuzzy Solution of Linear–Nonlinear Partial Differential Equations. Mathematics, 10(13).

Omer, O.A., Saibi, K., Abidin, M.Z., & Osman, M. (2022). Parametric Marcinkiewicz Integral and Its Higher-Order Commutators on Variable Exponents Morrey–Herz Spaces. Journal of Function Spaces, Article 7209977.

Osman, M., Almahi, A., Omer, O.A., Mustafa, A.M., & Altaie, S.A. (2022). Approximation Solution for Fuzzy Fractional-Order Partial Differential Equations. Fractal and Fractional, 6(11).

Osman, M., Xia, Y., Marwan, M., & Omer, O.A. (2022). Novel Approaches for Solving Fuzzy Fractional Partial Differential Equations. Fractal and Fractional, 6(11).

Osman, M., Gong, Z., Mustafa, A.M., & Yang, H. (2021). Solving Fuzzy (1+n)-Dimensional Burgers’ Equation. Advances in Difference Equations, Article 3376.

Helton Santiago | Inflammation | Research Excellence Award

Published on by sciencefather

Assoc. Prof. Dr. Helton Santiago | Inflammation | Research Excellence Award

Federal University of Minas Gerais | Brazil

Assoc. Prof. Dr. Helton Santiago is a distinguished immunologist whose career bridges clinical research, infectious disease immunology, and vaccine development. He earned his medical degree followed by a master’s and Ph.D. in Immunology of Infectious Diseases, later completing advanced postdoctoral training in leading U.S. institutions, where he deepened his expertise in parasitic diseases, allergy, and immune regulation. Over the years, he has held key academic and research positions, including roles at renowned universities and national research institutes, contributing to major programs in dengue, Zika, COVID-19, helminth infections, Chagas disease, and leishmaniasis. His experience spans directing clinical trials, leading Phase I–III vaccine studies, developing early-stage vaccine candidates, and conducting translational research on regulatory T cells, cytokines, biomarkers, allergy, inflammation, and cancer immunology. His scientific leadership is reflected in service on ethics committees, biosafety boards, IRBs, and clinical trial oversight groups. Dr. Santiago’s innovative contributions have earned multiple national and international awards, including recognitions for medical innovation, scientific merit, and outstanding doctoral research. His work continues to advance understanding of immune mechanisms and support the development of groundbreaking vaccines and therapeutic strategies, reinforcing his role as a prominent figure in global immunology and translational medicine.

Profiles: Scopus | Google Scholar

Featured Publications

Bafica, A., Santiago, H. C., Goldszmid, R., Ropert, C., Gazzinelli, R. T., & Sher, A. (2006). “TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection” in The Journal of Immunology.

Diemert, D. J., Pinto, A. G., Freire, J., Jariwala, A., Santiago, H., Hamilton, R. G., Periago, M. V., Loukas, A., Tribolet, L., Mulvenna, J., Correa-Oliveira, R., Hotez, P. J., & Bethony, J. M. (2012). “Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths” in Journal of Allergy and Clinical Immunology.

Canesso, M. C. C., Lemos, L., Neves, T. C., Marim, F. M., Castro, T. B. R., Veloso, É. S., Queiroz, C. P., Ahn, J., Santiago, H. C., Martins, F. S., Alves-Silva, J., Ferreira, E., Cara, D. C., Vieira, A. T., Barber, G. N., Oliveira, S. C., & Faria, A. M. C. (2018). “The cytosolic sensor STING is required for intestinal homeostasis and control of inflammation” in Mucosal Immunology.

Dos Santos, P. V. A., Roffê, E., Santiago, H. C., Torres, R. A., Marino, A. P. M. P., Paiva, C. N., Silva, A. A., Gazzinelli, R. T., & Lannes-Vieira, J. (2001). “Prevalence of CD8⁺ αβ T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L⁻LFA-1⁺VLA-4⁺ activation phenotype and expression of IFN-γ” in Microbes and Infection.

Santiago, H. C., Feng, C. G., Bafica, A., Roffe, E., Arantes, R. M., Cheever, A., Taylor, G., Vieira, L. Q., Aliberti, J., Gazzinelli, R. T., & Sher, A. (2005). “Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth” in The Journal of Immunology.

Bethony, J. M., Simon, G., Diemert, D. J., Parenti, D., Desrosiers, A., Schuck, S., Fujiwara, R., Santiago, H., & Hotez, P. J. (2008). “Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults” in Vaccine.

Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Published on by sciencefather

Mrs. Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Hilab | Brazil

Mrs. Aléxia Thamara Gasparin is a dedicated biotechnology and pharmacology professional whose academic and research journey reflects strong commitment to scientific advancement and health innovation. She holds a technical qualification in Biotechnology and Industrial Bioprocesses from SENAI-PR, a Bachelor’s degree in Biological Sciences from the Federal University of Paraná (UFPR), and a Master’s degree in Pharmacology from UFPR. Throughout her education, she developed extensive laboratory expertise, particularly in evaluating the pharmacological potential and adverse effects of bioactive compounds, and she actively participated in specialized training programs in pharmacology, psychopharmacotherapy, epigenetics, and animal handling. Her professional experience includes significant contributions to research projects focused on antinociceptive and anti-inflammatory mechanisms, as well as the development of interactive and didactic scientific materials. She also played a key role in science outreach and health-related extension activities. Currently, she is part of the research and development team at Hilab, where she contributes to the innovation of remotely operated laboratory tests (RTL) and internationally patented products designed to expand access to healthcare technologies in Brazil. Her achievements include top rankings and awards in scientific presentation events, highlighting her proficiency and dedication. Aléxia continues to build a meaningful career focused on pharmacology, biotechnology, and health democratization.

Profile: Scopus

Featured Publication

Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis

Author: Cannabis and Cannabinoid Research

Year: 2024